Solas BioVentures

Funding rounds backed by Solas BioVentures.

Export CSV
Funding disclosed in full
$5.7M
Median round
$5.7M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Aurenar

Developer of a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in ICU patients.

$5.7MSeedHealthtechUnited States
4 participantsBJC HealthGo Red for Women Venture FundKaleida CapitalSolas BioVentures